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A simple computational method for the identification of disease-associated
loci in complex, incomplete pedigrees
Gregory Leibon,1,5 Dan Rockmore,1,2,5 and, Martin R. Pollak3,4
ABSTRACT
We present an approach, called the Shadow Method, for the identification of disease loci from dense
genetic marker maps in complex, potentially incomplete pedigrees. Shadow is a simple method based
on an analysis of the patterns of obligate meiotic recombination events in genotypic data. This method
can be applied to any high density marker map and was specifically designed to exploit the fact that
extremely dense marker maps are becoming more readily available. We also describe how to interpret
and associate meaningful P -Values to the results. Shadow has significant advantages over traditional
parametric linkage analysis methods in that it can be readily applied even in cases in which the topology
of a pedigree or pedigrees can only be partially determined. In addition, Shadow is robust to variability in a
range of parameters and in particular does not require prior knowledge of mode of inheritance, penetrance
or clinical misdiagnosis rate. Shadow can be used for any SNP data, but is especially effective when
applied to dense samplings. Our primary example uses data from Affymetrix 100k SNPChip samples in
which we illustrate our approach by analyzing simulated data as well as genome-wide SNP data from
two pedigrees with inherited forms of kidney failure, one of which is compared with a typical LOD score
analysis.
Subject headings: SNP, LOD score, complex pedigree
1. Introduction
Studies of genetic disease have been remarkably
successful in identifying disease genes and novel bio-
logical pathways. For family-based analyses of pheno-
types with single, highly penetrant disease alleles, the
first step is the identification of a locus harboring the
mutant allele. This requires the acquisition and subse-
quent analysis of a significant amount of genetic data.
As regards the former, the ease with which investiga-
tors can accomplish genome-wide genotyping has in-
creased tremendously in recent years. For example,
one commercial microarray technology (Affymetrix
SNPChip) now allows rapid chip-based genotyping of
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approximately 10, 000, 100, 000, and 500, 000 SNPs
(see Matsuzaki et al (4) and (5)).
Most of the currently available linkage approaches
were originally developed with the goal of extract-
ing as much information as possible from a relatively
small set of markers. We base our approach on the
fact that with very dense genetic maps, we can ignore
markers that are not fully informative and still extract
most of the useful genetic information. In essence,
our method is based on identifying obligate recombi-
nation events and using the distribution of these events
to identify genomic regions inherited identical by de-
scent (IBD). This allows us to handle the complicated
requirements of real data and the often complex and
incompletely known structures of available pedigrees.
We call our technique the Shadow Method and intro-
duce it in the next section.
Our motivation for the development of Shadow is
severalfold. Perhaps most important is the fact that
available software is overmatched by the great number
of computations required in order to calculate paramet-
ric or non-parametric LOD scores for large pedigrees
1
and large data sets. It is known that using standard
methods, the size of the calculation (as measured in
the number of arithmetic operations) increases expo-
nentially in pedigree size or number of markers used
(the various elaborations of the Elston-Stewart algo-
rithm as in Ott (6) and the NPL algorithm as Kruglyak
et al (3) respectively). In contrast, the computational
load of Shadow only grows linearly with the number
of markers and at a rate that is less than exponential in
pedigree size. In the worst case scenario, it increases
exponentially in sample1 size, but is independent of
pedigree size. This enables us to analyze large pedi-
grees.
Computational complexity is just one concern. We
are also cognizant of the fact that in analyses of large
complex pedigrees, it can be extremely useful for in-
vestigators to have an index of which regions are most
likely to harbor disease genes by virtue of the of shar-
ing regions IBD in affected individuals, as well as a
measure, given data from a subset of a pedigree, of
distance from IBD for any region of the genome. This
relies on the computation of something we call the
Shadow function at the locus x, denoted S(x). It is
effectively a measure of just how inconsistent the data
is with the hypothesis that the pattern of inheritance
at a given locus is from IBD. In particular, S(x) = 0
implies IBD at x.
Thus, the Shadow method is a conceptually and
computationally simple technique with several fea-
tures that we believe make it useful for the analysis
of large, complex, and perhaps incomplete pedigrees,
particularly for relatively rare diseases caused by un-
common genetic variants of large effect: (1) Shadow
enables rapid identification of genetic regions most
likely to harbor IBD regions in pedigrees; (2) Shadow
measures how inconsistent such regions (and in fact all
regions) are from being IBD; and (3) Shadow helps to
identify the source of such inconsistencies in “almost
IBD” regions. We also develop methods to assess how
likely we are to find such IBD or “almost IBD” re-
gions by chance. The specifics of this measure and the
details of its interpretation are presented in the next
section.
We illustrate the use of Shadow by analyzing both
simulated data as well as genome-wide SNP data from
two pedigrees with inherited forms of kidney disease.
1 In this paper we draw the distinction between the pedigree members
and the samples, the latter of which are those people in the pedigree
for whom we possess a genotyped DNA sample.
The pedigrees are illustrated in Figure 1. The family
FS-Z has a relatively simple pedigree and it is known
that the responsible gene defect is a point mutation
in the TRPC6 gene on chromosome 11q (Reiser et al
(2)). In this case a full multi-point linkage analysis will
work well and we compare our results to a LOD score
analysis. The second family we analyze, the FG-FM
family, has an incomplete and large pedigree, a situa-
tion which makes standard linkage approaches unreli-
able and/or impossible.
2. The Shadow Function - Measuring distance
from IBD
2.1. Definition of Shadow function
At the core of the Shadow method is the idea that
the sample data provides us with a means to mea-
sure for each locus x the degree to which the data
is inconsistent with the hypothesis that the region
around x is IBD and thus is possibly within a disease-
harboring allele. We call this measure the Shadow
function and denote it as S. Since we focus on in-
consistency, a locus x that is consistent with the IBD
assumption has S(x) = 0, reflecting that it is distance
0 from being IBD.
To articulate this distance we use the familiar notion
of an inheritance vector, as introduced in Kruglyak et
al (3). Recall, an inheritance vector v is a vector of
ones and zeros that tells us which copy of a marker is
passed on during a particular meiosis process in our
pedigree. In particular, if we label one of the chromo-
somes in each homologous chromosomal pair with a
zero and the other with a one, then we have an inheri-
tance vector v(x) defined at each locus x. The value of
S approximates the minimal number of changes in the
inheritance vector necessary for v(x) to be ideally con-
sistent with a disease allele being located at that point
x. Since our examples use only affected samples, this
gives us an estimate of the minimal number of changes
in the inheritance vector necessary for inheritance vec-
tor at x to be IBD. In Section 4 we explain how to
include controls.
The exact sense of distance is captured by the fol-
lowing definition:
Definition: For a given inheritance vector v, let
m(v) denote the minimal number of changes (bit-flips)
necessary to make the vector IBD. We call a partition
of our samples2 consistent with a given inheritance
2A partition of the set of samples is simply its decomposition into a
2
vector v if the samples in each part of the partition
are IBD from some common founder using v. We let
Part(v) be the set of the partitions consistent with v.
Similarly we denote as Inh(P ) the set of inheritance
vectors with which P is consistent. Then we define S
to be
S(x) = min
P∈Part(v(x))
(
min
v∈Inh(P )
m(v)
)
.
For example, for a simple pedigree with autoso-
mal dominant inheritance and 0% phenocopy rate,
S(disease locus) = 0.
Figure 2 gives us a first illustration of the function
S. The Shadow in Figure 2 was constructed from a
simulated FS-Z family assumed to have the disease
at 1 morgan from the p end of the chromosome 11.
That is, we ran twenty simulations of allele segrega-
tion in chromosome 11 consistent with the pedigree
for FS-Z and a disease locus at the TRPC6 locus and
chose two IBD regions for illustrative purposes. Hence
S(Ch 11, 1 morgan) = 0 since this location is fully
consistent with harboring a disease allele. Each time a
crossover occurs in meiosis, there is a change in the in-
heritance vector. There are crossovers on both sides of
the disease locus, and as we move from the disease lo-
cus past such a crossover the value of S goes from 0 to
1. In general, the “corners” of the Shadow curve (see
Figure 2) will represent crossovers that have had an ef-
fect on what our data will look like from the point of
view of our samples. Notice that we have used a con-
vention where the distance-axis (y-axis) has its min-
imal value of 0 at the top and increases as we move
down the axis.
In real data, at the disease locus x the Shadow may
have S > 0. In such a case, the value of S is easy to
interpret. Namely
S(x) = #of inconsistencies
where an inconsistency may be either an unanticipated
founder or a person who has an indistinguishable phe-
notype but not a disease allele (i.e., a phenocopy).
2.1.1. How to use S - the P -Value
The use of S is very similar to the use of the LOD
score function LOD(x). Figure 3 compares the two.
In particular, if we knew S but not the disease locus
collection of disjoint subsets.
(or loci), then we would identify the region(s) in the
genome where S is minimal are likely candidates. The
next step in the evaluation of such regions is to deter-
mine how likely it is that such a scenario is the result
of chance alone. We call the probability of this sce-
nario being due to chance alone the event’s P -Value.
If the P -Value is small, then we can conclude with
some specific computed probability that the certainty
that a disease locus is in this region and interpret the
value of S at this point as the number of inconsisten-
cies. As with the LOD score method (or any method)
if this P -Value is large then it will be difficult to distin-
guish a disease allele-harboring region from a chance
IBD region and this will lead to a high false positive
rate. In Section A we review the process of estimating
the P -Value. For example, if we make the definitions
chi = Morgan length of chromosomei
and
B = #(Branches in collapsed pedigree)
for a tree we estimate
P < 4
22∑
i=1
B · chi + 1
2B
.
In general, the size and complexity of the pedigree will
influence the P -Value and hence the number of incon-
sistencies that can exist at a true disease locus in the
given family before this method will give false pos-
itives. Consider the pedigrees in Figure 1. We find
that in the FS-Z pedigree, the presence of any incon-
sistency will be fatal. By contrast, in the FG-FM fam-
ily a single inconsistency would still yield significant
results. Specifically, a region where S = 1 could still
be regarded as likely to harbor a disease allele, given
the existence of one inconsistency as defined above.
2.2. Approximation of the Shadow function
In practice we do not have access to the actual
Shadow, but an approximation denoted as SM . The
idea behind this approximation is very simple, namely
that we can identify obligate recombination events be-
tween two individuals if they have incompatible alleles
at some marker. With our SNP data if we see that Per-
son 1 has alleles AA at the same SNP locus where Per-
son 2 has alleles BB then we have an obligate recombi-
nation event. With a very dense and polymorphic SNP
map, we can be reasonably sure that if a sufficiently
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long consecutive stretch of SNPs occurs without such
an obligate recombination event, then these individu-
als share (at least) 1 chromosomal region identical by
descent. We say that such a streak of markers is con-
sistent with a partition P (of samples) if each part of
the partition contains no obligate recombination events
throughout the streak.
We will view the streak as a non-coincidence if it
exceed the critical length ofM markers (how to choose
M is explored at length in Section 3.2).
Definition: Let PartM (x) be the set of partitions
with the property that there exists a streak of length at
least M and containing x that is consistent with this
partition. Then we define SM to be
SM (x) = min
P∈PartM (x)
(
min
v∈Inh(P )
m(v)
)
.
Denser marker maps allow us to obtain better and
better approximations to the true Shadow. Figure 2,
shows a sequence of such approximations for simu-
lated 10k, 100k and 500k SNP data for our FS-Z fam-
ily. We applied our 10k approximation to the real FS-
Z 10k data, and found a unique interval on chromo-
some 11 where S58(x) took on its minimal value of
0 as seen in Figure 3 (the choice of 58 is discussed
in section 2.3.1). As published in ((2)), this is the
location of the TRPC6 gene that harbors the disease
causing allele. The Shadow curve S200(x) for the FG-
FM family can be seen in Figure 5. Here we see a
unique S200(x) = 1 interval on chromosome 22. In
Section A, we see that P ≈ 125 for such a region oc-
curring somewhere in the genome, and so its existence
is statistically significant and would be our best can-
didate for a disease harboring gene locus. In the Sec-
tion 3 we explore and sharpen this FG-FM candidate
using the Shadow Method.
2.3. Analysis of the Shadow
Notice in the definition of SM we only consider
partitions which are consistent with a streak of length
greater than or equal to M . We encounter two poten-
tial problems when choosing M . For M too large, we
run the risk of false negatives. We quantify this with
what we call Q-Value as introduced in Section 2.3.1.
For M too small, we encounter false positives, as dis-
cussed in Section 2.3.2. In Section 3.2 we see that us-
ing these notions we can make sensible choices forM .
In Section 3.2 we will also see that as the number of
SNPs gets larger it will be possible to chooseM so that
there is simultaneously a very small chance of a false
positive and a very small chance of a false negative.
2.3.1. False Negatives
Figure 2 shows that for the 10k and 100k SNP sets
there are regions where S exaggerates how far x is
from being in an IBD region, a situation that will lead
to false negatives in our hunt for disease loci. In fact,
in both the 10k and 100k examples we see that the
method entirely missed the small IBD region to the left
of the IBD region harboring the disease-causing allele
at x = 1. We would like to compute the probability
that we miss the true disease-allele harboring region.
We call this probability the Q-Value and find in Sec-
tion B that if we define
G =
∑
chi
N = #(SNPmarkers)
then we have
Q = 1−
(
1 +
MBG
N
)
e−
MBG
N .
Fixing the Q-Value is a very natural way to choose M .
For example, in Figure 2 for the 100k simulation we
chose M = 103 since this corresponds to Q = 0.05
and for 500k we chose M = 217 since this corre-
sponds to Q = 0.01 . We chose M = 58 for the
10k data since it corresponds to detecting a region that
is at least as long as the expected length of a disease
causing region.
A reasonable question might be: Why did we not
simply choose them all so that Q = 0.01? The prob-
lem is that then the 10k and 100k analyses will then
become cluttered with false positives, the subject of
the next section.
2.3.2. False Positives
Notice in Figure 2 that in the 10k and 100k cases
there are regions where the value of S exaggerates how
close we are to being at an IBD region, a situation that
will lead to false positives in our hunt for disease loci.
In Figure 4 we see an example of an SM = 0 false
positive region, and we can estimate the probability of
such a false positive in the genome as follows. Let
S = #(Samples for which we have SNP data)
p ≈ P (More Likely SNP Allele)
4
q = 1− p
pj = pq((1− pS−j)(1 − qj) + (1 − qS−j)(1 − pj))
pmax = max{pj | 1 ≤ j ≤ ⌊S/2⌋}
pmin = min{pj | 1 ≤ j ≤ ⌊S/2⌋}
then we have that this false positive rate FP satisfies
FP < Npmax(1− pmin)M .
Notice, the Q-Value improves as M
N
decreases. On
the other hand, the larger the choice of M the smaller
the false positive rate. Hence there is a balance be-
tween making M large in order to shrink the noise and
making M
N
small in order to shrink the Q-Value. Ex-
plicit examples of this balancing act are given in Sec-
tion 3.2.
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Fig. 1.— Examples of collapsed pedigrees of the families analyzed here. A collapsed pedigree only includes people
for whom there exist a genotyped DNA sample (in green), the non-founders (in blue), and founders that in the ideal
disease associated scenario contributed a disease allele (in red). Red edges are hypothetical and a, b, and c represent
the number of non-founders along the hypothetical edge. For the FG-FM family this is a minimally complicated
pedigree consistent with a unique “red” founder and in our analysis we assume a = c = 1 and b = 2.
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Fig. 2.— Here we see a simulation the genetic process in the FS-Z family on chromosome 11 (see Section A). We
have plotted the simulation’s Shadow using a red line. The black curves are approximations of the Shadow using: (A)
10k SNPs data, then (B) 100k SNPs data. We choose our Shadow by simulating the genetic process 20 times and
picked one with a a second chance IBD region for illustrative purposes. That we expect such chance IBD regions is
due in part to the fact that the P -Value for an IBD region is large for the FS-Z pedigree (see Section A).
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Fig. 3.— The black curve is S 58 for the real FS-Z family data on chromosome 11. In the next Figure, we compare S58
to LOD(x) in red as computed by the Genehuneter2 program as implemented by the dCHIP program (see Kruglyak
et al (3) and Leykin (8)). The LOD score values are on the right hand y-axis.
0.0 0.5 1.0 1.5
3
2
1
0
Actual Shadow
Morgan measure  on chromosome 11
D
is
ta
nc
e 
fro
m
 IB
D
0.0 0.5 1.0 1.5
3
2
1
0
100K, Q=0.05 Shadow Approximation
Morgan measure  on chromosome 11
D
is
ta
nc
e 
fro
m
 IB
D
Fig. 4.— Here we see an example of a false positive IBD region in our FS-Z family arising in a simulation.
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Fig. 5.— The black curve outlines S200(x) in black for the whole genome and the FG-FM family’s actual SNP data.
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3. The Shadow Method
For both the 10k data on family FS-Z and the 100k
data on the FG-FM family it is impossible to simul-
taneously make Q and FP small. By taking a more
careful look at the data we are still able to reduce the
Q-Value.
We use the fact that near a disease locus, S has a
very distinct tiered or “wedding cake” shape. More
precisely a true S = 0 region sits on top of an S = 1
region which sits on top of an S = 2 region and
so on, each layer requiring at least a pair of obligate
crossovers to make the transitions between the tiers.
In Figure 3 we see a very typical example. This struc-
ture allows us to detect an S = 0 level by searching for
a cake with a long S = 1 region as its top layer. This
technique will work best when such candidate regions
are themselves rare, for example in the FG-FM fam-
ily. Armed with such candidates we can take a more
detailed look at the definition of S. Namely, we notice
that when approximating the Shadow, at each point in
the genome we obtain a list of partitions of the samples
that are compatible with the data and these partitions
can be used to provide greater insight into the disease
loci. It is the full use of this information that is called
the Shadow Method. The analysis of these partitions
takes two primary forms that we will now explore.
The first case is as in Figure 7, where we see an
example of a large S = 1 region on chromosome 2
in the FS-Z data that looks a lot like a cake missing
its top layer. We find that the left half is given by the
partition consisting of {113, 114, 115} and its comple-
ment, while the right half is determined by the single-
ton {213} and its complement, and in the middle the
two partitions are both consistent. This is indicated
schematically on the right hand side of Figure 7. How
can this happen? The most likely possibility, as illus-
trated in Figure 7, is that there is an IBD region sepa-
rated by crossovers as indicated. Whenever an S = k
region is comprised of a pair partitions which differ
by incompatible obligate crossovers that intersects in
a region compatible with the removal of these obligate
crossovers, we can deduce the likely existence of an
S = k − 1 region.
This method also applies to the FG-FM family,
though in a second weaker form. Once again we will
explore the possibility of an IBD region in the SM = 1
candidate region. In this case there is a unique parti-
tion that gives our candidate SM = 1 interval and it is
composed of the samples {b1, b12c111} and this set’s
complement. If we believe that an IBD region might
be present, then we would conclude that the true pedi-
gree is more likely to look something like the pedi-
gree in Figure 6, with the relatively large number of
non-founders d+ b compared with the number of non-
founders a + c. With d + b relatively large there are
many chances for crossovers near the disease locus and
hence the IBD region may be quite small. To explore
this possibility, we can look at an approximation with
a better Q-Value, like S50(x) as in Figure 8. Using
S50(x) we find a candidate IBD region. The assump-
tion that b + d is relatively large compared with a+ c
makes plausible the scenario for the IBD region’s ex-
istence as pictured in the right half of Figure 8. Fur-
thermore, this IBD streak has a length of 60 markers
and having a streak this long inside of our length 283
S = 1 region by chance is unlikely. Namely, in Sec-
tion C, we find that the probability of a streak this long
or longer due to chance is less than 0.12. While this
argument is not as convincing as the earlier example
with the FS-Z family (where the S = 1 region was
comprised of two partitions), this still gives us a good
first place to look for a disease allele.
A key aspect of this method that we still need to
discuss, is how to choose M . The ideas is to choose if
possible an M that simultaneously makes the chance
of false positives and false negatives using the full
Shadow Method small. In the next section, we esti-
mate the false negative rate using the Shadow Method
and in Section 3.2 demonstrate how to use the false
negative rate to choose M .
3.1. False negatives revisited
By applying the Shadow Method (and not simply
attending to the regions where S = 0) reduces the
false negative rate. We call this improved estimate of
the false negative rate the FN -Value. Notice, Q cor-
responds to the false negative rate using just a streak
analysis, while FN corresponds to the false negative
rate using the full Shadow Method. In Section B, we
find that
FN = 1−
(
2 +
(
MBG
N
)2
− e−MBGN
)
e−
MBG
N .
In Section 3.2 we will quantify the extent to which this
method enhances the use of S via some examples. This
improvement in the false negative rate is the motiva-
tion behind the introduction of the full Shadow Method
(as opposed to performing only a longest streak analy-
sis).
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3.2. Estimates
First let us review. The following parameters will
be considered:
M = Streak length lacking obligate recombinations
B = Branches in collapsed pedigree
N = #(SNPmarkers)
D = #(Samples for which we have SNP data)
p ≈ P (More Likely Allele).
It is possible to assess from these parameters the po-
tential effectiveness of the relevant Shadow Method.
For example, using M = 200 and N = 100k we find
for our example pedigrees:
P FP FN Q
FS − Z 1.4 (10)−4 0.01 0.15
FG− FM 4× (10)−4 (10)−5 0.17 0.55
N = 100k and M = 200
These values indicate with M = 200, the FS-Z
pedigree would be handled very nicely via 100k SNP
marker sets since both FN and FP are reduced below
1
100 (though the P -Value for this family is weak and
we would expect that we would need to carefully try
to list all the IBD regions, see Section A.1.) For the
FG-FM family we see that M = 200 has a small FP
but a rather large FN . If we were to try M = 50 we
have the opposite problem
P FP FN Q
FS − Z 1.4 114 6× (10)−5 0.01
FG− FM 4× (10)−4 65 0.002 0.08
N = 100k and M = 50
in which FP is very large and FN is small. Ex-
ploring these values we see that we must make a com-
promise. For example, for M = 100 we have:
P FP FN Q
FS − Z 1.4 1.2 (10)−3 0.05
FG− FM 4× (10)−4 .32 0.025 0.23
N = 100k and M = 100
If we don’t wish to compromise we will need to use
a denser mapping. For example, using 500k SNPs and
M = 200 we have:
P FP FN Q
FS − Z 1.4 (10)−3 (10)−4 0.01
FG− FM 4× (10)−4 (10)−4 (10)−3 0.05
N = 500k and M = 200
Hence we see in this case the extra SNPs would re-
ally pay off.
These estimates also give a sense of the future for
SNP technology. It is widely estimated that on av-
erage, two genomes differ at 1 in 1000 nucleotides
(i.e., approximately 3 million variants per genome).
Hence, it is quite reasonable that we may find 5000k
reasonably informative SNPs. In this case a Shandow
based approach applied to a collapsed pedigree with 50
members, of which 10 are affected and sampled, then
using M = 190, both Q and FP would be less than
1/500.
3.3. Assumptions and Caveats
Here we discuss the assumptions that underlie our
analysis. We assume that the markers occur ran-
domly (with respect to morgan measure) throughout
the genome and that the rates in the founder popula-
tion of the more common marker alleles behave as if
they were randomly distributed among the SNPs. Vi-
olations of these assumptions will make some IBD re-
gions easier to find and some harder. Moreover, it is
well known that such a random independent distribu-
tion is not going to be accurate SNP rates at which
linkage disequilibirum is observed (see Altshuler (7))
and the SNPs in haplotypes contain less information
do to the violations of independence.
Another simplifying assumption we make is that we
can make a reasonable choice of a collapsed pedigree
with a common founder. Of course on some scale,
many ancient founders of all or most of the affected
samples will exist. However, most such founders are
too genetically distant to be picked up with our meth-
ods. It is also much less likely that one of these al-
ternate distant founders has introduced a disease allele
into our population, at least for rare diseases caused by
alleles of strong effect.
In general, the need to apply the full Shadow
Method will become less necessary to as the marker
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densities increase and the Q-Value shrinks. However
our estimation techniques rely on assumptions which
are reasonable for the current SNP densities but may
hamper the exploration of very large pedigrees with
very dense SNPs. For example, this 500k and 5000K
estimates form the previous section assume that the
more common of the two SNP alleles occurs on aver-
age no more than about 85% of the time in the founder
population, which is true in our 10k and 100k sam-
ples but may increase as SNP density increases hence
increasing FP (see Section C).
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Fig. 6.— On the left we see the low noise S200(x) on chromosome 22 in our FG-FM family. The partition of the
samples responsible for the SM = 1 region is {b1, b12c111} and this set’s complement. On the right we see a version
of the FG-FM pedigree consistent with a disease locus on chromosome 22 as discussed in Section 3.
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Fig. 7.— Here we see the next most promising candidate region in FS-Z, the large S = 1 region on chromosome 2. In
Section 3, we conclude the likely existence of an IBD region inside this S = 1 region. In the right half of this of this
Figure we see plausible positions in the pedigree for the obligate crossovers (indicated with yellow squares) necessary
to form the indicated partitions as determined by the Shadow Method.
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Fig. 8.— On the left we see the noisier S50(x) that exposes our most likely candidate IBD region. As in Figure 7, on
the right we explore the plausible IBD region.
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Fig. 9.— “The Disease Paradox”: Assuming no a priori knowledge of the location of the disease loci, we have that
the chance of the disease being located in any given crossover interval is proportional to the length of the interval.
Hence the probability density function (pdf) of the length of the interval containing the disease fDisease(l) satisfies
fDisease(l) ∝ lfChance(l) where fChance(l) is the pdf of the of length of a chance IBD region. The green curve in
this figure is the distribution of the SNP length of a chance IBD region, while black curve is the distribution of the
SNP length of a region which is IBD because the disease is conditioned to be there. These curves were derived using
the independence model discussed in Section B.
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4. Computational Methods
The main purpose of this section is to discuss the
complexity of the algorithm 3 used to compute the
Shadow and perform the Shadow Method. To make
this analysis we use the parameters reviewed in Sec-
tion 3.2 together with the definitions:
T = # of branches remaining upon removal of the
non-genotyped pedigree members (as in the pedigrees
on the left hand side of Figure 8)
and
H = the maximal number of inconsistencies that we
will be considering in the computation of the Shadow.
For example, for the FS-Z family T = 7, we choose
H = 3, and D = 6 (recall D is the number of sam-
ples).
The algorithm requires knowledge of the confi-
dence call for a SNP, and one must choose how to
throw away suspicious measurements. This parame-
ter is important since the Shadow Method is not robust
under SNP miscalls. (We used parent/child compar-
isons to help interpret this error rate and found that
a cutoff of 0.01 using the Affymetrix confidence call
works well.)
The analysis of the Shadow presented in the previ-
ous section made use of an approximate pedigree. This
pedigree should be used only if there is a great deal
of confidence that the disease allele is likely to be af-
fecting the samples via these known relationships. The
real power of the Shadow Method is that it allows us to
be more flexible if we are uncertain about the pedigree
or of the pedigree’s role in the spread of the disease.
Any likely pedigree can be used, but the complex-
ity increases with each possibility. Denote as PedH
the collection of all partitions with m(v) ≤ H − 1
in the pedigree(s) of interest. Then the complexity is
O(N |PedH |). If there is just a single pedigree to in-
vestigate then we have the universal bound |PedH | ≤∑H−1
k=0
(
T
k
)
. For a tree4 this bound is sharp, and for
(the tree) FS-Z |Ped3| = 29. Notice if we have a list
of candidate collapsed pedigrees then PedH is easy to
construct by simply adding in crossovers to the pedi-
grees and recording the resulting partitions. Typically,
given a pedigree in which there is confidence both in
the pedigree structure and clinical data, then this algo-
3 The complexity of an algorithm is the number of arithmetic opera-
tions required.
4We mean here ”tree” in the graph theoretic sense - that is a graph
without loops
rithm will work for very large pedigrees and number
of samples (certainly T and S both less than 22 will
work).
However, in practice the Shadow Method will be
most useful when pedigree information is missing. If
we are completely open-minded about the pedigree
structure, then |PedH | is less than or equal to the num-
ber of partitions of a set of S elements into H − 1 or
fewer parts (and this number of parts determines the
m(v)). In other words, |PedH | =
∑H−1
k=1
{
D
k
}
where
{
D
k
}
is a Stirling number of the second kind.
This sum grows exponentially and nearly at the rate
(H − 1)D. For the FG-FM analysis, we performed a
completely open-minded analysis and choose H = 4.
On our machines, we could not exceed not exceed
S = 11 and H = 4 with 100k data. One important dif-
ference between this method and other forms of link-
age analysis is that the size of the pedigree does not af-
fect computational speed. Rather the number of sam-
ples studies (irrespective of the structure of the pedi-
gree) determines computational size and speed. This
will allow for the analysis for very large and compli-
cated pedigrees.
Comments About Controls: This algorithm (and
the Shadow Method itself) can be altered to incorpo-
rate controls. For example: Call a region ideally con-
sistent with disease (ICD) if the affected samples are
IBD in this region and the unaffected samples are not
related to each other or the affecteds in this region.
Then we can search for how far we are from an ICD
region using the same exact techniques as that we de-
signed to search for how far we are form an IBD re-
gion. For example, the partition having a part for each
unaffected and a part for all the affected would now
have S = 0, and we would be estimating the distance
from this situation. be said that in this case, more in-
consistencies should be expected, since the penetrance
rate for a single allele might be very low. (Especially
if the disease is recessive. However, at a potentially re-
cessive allele the algorithm can be modified to break a
streak if an AB is observed, hence isolating the region
around a recessive disease locus. Under the assump-
tion that both mutant alleles are the same, which is of
course a very strong assumption.) To optimally exploit
sibling and parental controls with such a streak analy-
sis requires more work and a haplotyping version of
the method, work we hope to describe this in future
paper.
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5. Discussion
We have described a simple method for identifying
disease gene loci in pedigrees using dense genetic data.
We believe this method has several strengths. In any
family-based study designed to identify loci harboring
rare alleles of strong effect, the goal is to identify a
genetic locus (or loci) harboring alleles cosegregating
with a phenotype of interest. The Shadow function de-
fined here gives an intuitive interpretation of dense ge-
netic data. At each point in the genome, Shadow tells
us how inconsistent that point is from being located in
a genetic region shared by a group of phenotypically
“affected” individuals. These S = 0 regions are sim-
ilar to regions where the LOD score reaches its maxi-
mum attainable value. However, in contrast to a LOD
score, the Shadow is not itself a likelihood ratio. Thus,
for a family consisting of a single pair of affected sibs,
S = 0 for half of the genome, and S = 1 for the other
half. In this method, statistical significance is assessed
separately. We assign to each value of S a P -Value
which describes the probability of seeing this value by
chance. We also generate FP and FN values, so that
we can assess the chances of a false positive and false
negative using this method. In turn, these estimates
allow us to make a priori estimates of an appropriate
choice of the key parameter M , the length of a streak
of markers lacking obligate recombination events.
In addition, the Shadow Method helps us identify
the cause of deviations from S = 0 regions. For exam-
ple, in a genome-wide analysis, we may find no S = 0
region, but a small number of S = 1 regions. We
can specifically examine the nature of the one incon-
sistency in each such region to help us evaluate the
plausibility that a phenotype-causing allele is in fact
present.
This method has limitations. There is certainly no
practical reason to use Shadow to analyze a pedigree of
the size of FS-Z where a standard linkage analysis with
a map of only moderate density will work well. While
at the currently routinely available SNP map densities
(such as Affymetrix 10k and 100k SNPChips) the as-
sumptions we use in our analysis appear reasonable,
we must hope that the nature and quality of SNPs does
not change in significant ways as densities increase or
our estimation method will fail to make good sense and
will need to be modified.
As noted, we plan to develop further refinements
of this methodology allowing the incorporation of a
greater fraction of the available genetic information
as well as data from controls and unaffected family
members. However, in its present form, we believe
Shadow will have immediate value in the analysis of
genetic data in complex family studies in which tradi-
tional linkage analysis calculations are problematic.
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A. P -Value
Here we explain how to approximate the required P -Values. We carefully justify our computation in the basic
case where P is the probability of an IBD region (S = 0 region) and the approximate pedigree is a tree; we then
explain how modify the answer for other values of S and more complicated pedigrees. The first observation is that
this P -Value is bounded by the expected number of IBD regions, and it is this quantity that we compute.
For each pair of spousal founders there are four chromosomes which could be responsible for a given IBD region.
We fix one of these four possibilities for the ith chromosome and call a region of the samples IBD relative to it IBDi.
Recall chi = E(Ci) where Ci is the total number of crossovers during a meiosis process on the ith chromosome. We
have
E(| IBDs|) = 4E(∑22i=1 #(IBDis))
= 4
∑22
i=1 E(E(#(IBDis) | Ci = N))
= 4
∑22
i=1 E(
N+1
2B )
= 4
∑22
i=1
Bchi+1
2B .
Notice this estimate of the P -Value is exponentially decreasing. In particular, if the collapsed pedigree is a tree
then for more than 16 branches the chance of a chance IBD is less than 5 percent, and if the number of branches is
greater than 20 then the P -Value of an chance IBD region is less than 1 in 500.
For a non-tree the numerator of 1
2B
would become the number of collections of crossover events that still leave our
samples IBD. For the FG-FM pedigree, we have one loop and find that number of collections of crossover events that
still leave our samples IBD equals 22 + 22 − 1. So the expected number of IBD regions is less than 12500 and hence
the P -Value associated to an IBD candidate is bounded by 12500 . For a general S = k, we must list all the partitions
that are consistent with k or fewer obligate crossovers and then count all the collections of crossover events that can
result in such partitions. We find that the probability of an S = 1 region in our FG-FM family is less than 125 .
A.1. When the P -Value is high
Using the computation in the previous section, in FS-Z we find that we expect 1.4 IBD regions from this pedigree
other than the one due to the disease. This explains why we should not be surprised to find at least two IBD regions
(as we see in Figures 3 and 7). In general, it important to list all the candidate regions when the P -Value is not
small. For example, under the assumption that we have no information about the location of our disease loci before
the experiment, we have the following theorem:
Key Theorem: Assuming the disease is in D = {x | S = k}, the probability that a given interval in D contains
the disease marker is proportional to that region’s length in D.
For example, using the Shadow Method we find three good candidate IBD region in the FS-Z family (the ones on
chromosomes 11 and 2 and another on chromosome 16) with morgan lengths roughly 0.2, 0.05 and 0.05. So assuming
the disease loci was in an IBD region, this key theorem tells us that we should have assigned an a priori probability of
roughly 2/3 of the disease loci being in chromosome 11 region (where it turned out to actually be).
B. False Negatives
Here we approximate the Q and the FN . To compute the Q, we first notice that the end points of the interval
corresponding to the interval with a disease locus are dictated by crossovers in the collapsed pedigree. The length of
a randomly selected such interval will have a length distribution corresponding to the distribution of the length of a
chance IBD region, and we denote the probability density function (pdf) of this length as fChance(l). As it turns out,
the disease is more likely to be in a longer interval. This fact sometimes goes by the name of the “Bus Paradox”, which
for the purposes (and context) of this paper, we will call rename the “Disease Paradox”. This is illustrated in Figure 9,
where we find the pdf of the interval containing a disease loci is fDisease(l) ∝ lfChance(l).
To determine fChance(l) requires a choice of model for the meiosis process. We use the standard independence
assumption that underlies the linkage analysis approach as developed in Lander et al (1) and call this model the
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independence model. Here is a brief review. We can view each chromosome as an interval with subintervals each
associated to an inheritance vector where neighboring inheritance vectors differ by exactly one change to the vector.
We call such an interval a crossover interval when we restrict our attention to the collapse pedigree (with respect to any
one of the four founding chromosomes). We need to decide how to choose the endpoints of these subintervals. There
is a natural measure on each chromosome which assigns to each interval the expected number of cuts during a meiosis
process, called the Morgan measure. In the case of multiple cuts during meiosis, the positions are not independently
chosen with respect to the Morgan measure (this is due to interference), but if we view the meiosis process associated
to distinct individuals in our pedigree as independent and note that the expected number of cuts per individual is small,
then a Poisson process should give an excellent approximation when examining even a moderate size pedigree. This
approximation is equivalent to the well studied Markov assumption as utilized in most forms of linkage analysis and
as developed in (Lander et al (1)) and in (Kruglyak et al (3)). This model is not directly utilized in the formulation of
our algorithm, but only utilized in order to analyze the results and it is also how we simulated the genetic process. (We
assumed independent founders and choose the cuts via this Poisson process.)
Under our Poisson assumption fChance(l) = Be−Bl, hence fDisease(l) = B2le−Bl. To estimate the Q-Value, first
note that M SNPs corresponds roughly to m = GM
N
morgans, and hence under these assumptions we can approximate
the the Q-Value via
Q = B2
∫m
0 le
−Bldl
=
∫ Bm
0 le
−ldl
= 1− (1 +Bm)e−Bm.
To approximate FN we can look one layer down in the tree. To do so, let L denote the length of the region to the
IBD region’s left and R the length of the region to its right. We have
FN =
∫m
0
P (R ≤ (m− l) and L ≤ (m− l))fDisease(l)dl
=
∫m
0 P (R ≤ (m− l))P (L ≤ (m− l))fDisease(l)dl
=
∫m
0
(1− e−B(m−l))2B2le−Bldl
= 1− (2 + (mB)2 − e−mB)e−mB.
C. False Positives
To explore noise we need to articulate a model of the SNPs themselves. We let SNPi denote the value of the ith SNP.
Each SNPi comes in one of two flavors, A or B. It is perhaps more useful to think of them labeled instead as Less and
More, representing the less and more common alleles. To model the distribution of the SNPs we would like to assign
a value ofMore with a probability that approximates the rate at which More would occur in a population of founders.
Let us call this probability P (SNPi =More). Note that if we intend to use a parametric maximum likelihood method
(as in (Kruglyak et al (3))), then it would be wise to carefully explore this distribution. However, for our purposes we
feel some simplifying assumptions are reasonable, namely that the population from which founders are drawn is large
enough so that the SNPi are independent, and that p = P (SNPi = More) is independent of i. We also used these
assumptions when simulating of SNPs. We acknowledge that these are very serious assumptions and will become
falser and falser for denser and desner maps, as dicussed in Section 3.3.
As introduced in Section 2.3.2, Noise is comprised of streaks of data accidentally consistent with a given partition
making SM (x) > S(x). Hence, we will define a unit of noise a to be a streak of length greater or equal to M where
SM (x) > S(x) throughout this streak. We let Noise in a region be the total number of such units of noise in that
region.
Let us start with an example of estimating noise from the FG-FM family by examining carefully our S = 1 region
on chromosome 22 in the FG-FM family. Here we have an interval of length L = 283 markers consistent with a
partition of our 8 samples with two parts, one of size 2 and the other size 6. Under our simplifying assumptions, we
claim that the expect noise in the the M = 50 Shadow is given by
E(Noise) ≤ Lpn(1− pn)M ,
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where pn = pq((1 − p6)(1− q2) + (1− q6)(1− p2)).
Proof: The observation is simple. We assign the position in our length L region a value of 1 if it starts a streak of
length greater than or equal to M and a 0 otherswise and denote the quantity as Posi. Each Posi is version of the
random variable Pos which is equal to 1 if M+1 flips of the coin are such that the first result is a tail, and the next M
give heads, this with a probability of tails equal to pn. Hence E(Pos) = Lpn(1− pn)M .
E(Noise) = E(
L−M∑
i=1
Posi) =
L−M−1∑
i=1
E(Posi) ≤ LE(Pos) = Lpn(1 − pn)M
Now we need to estimate the probability of tails. In order to have a tails outcome, we need the chromosomes that
are IBD for each part Allele(Part 1) 6= Allele(Part 2) and that at least one of the other founder chromosomes in each
part takes on the same allele value as the chromosome that is IBD for this part. Hence
pn = p(1− p6)q(1− q2) + q(1 − q6)p(1− p2))
as claimed.
QED
Of course to actually compute it we need an approximation of p. To do so, we first note that the probability that the
alleles are different, P (AB), equals 2p(1 − p). We can use our data to approximate P (AB) and solve this quadratic
to find p ≈ 0.84. (This corresponds to a maximum likelihood estimate of the parameter.)
If we use the whole genome as our region then FN < E(Noise) and it is this relationship we will use to bound
FN . To give a nice bound we use the special case of a tree, though only role this plays is in insuring that the chance
of an accidental consistent set of markers when S < 1 is less than the this chance when S = 1. Hence we can use the
S = 1 case with a unique corresponding partition to bound this probability. So we can assume there are two parts in
our partition of our D samples and hence the probability of success at any give point is bounded above and below by
pmax = max{pq((1− pD−j)(1− qj) + (1− qD−j)(1 − pj)) | 1 ≤ j ≤ ⌊D/2⌋}
pmin = min{pq((1− pD−j)(1 − qj) + (1 − qD−j)(1− pj)) | 1 ≤ j ≤ ⌊D/2⌋}
and the same argument as above tells us that
FP < E(IBD Noise) ≤ Npmax(1− pmin)M ,
and hence will give us a sense for the expected noise.
In general, such estimates tells us that if N is big enough we do not need to be very careful in analyzing our data
and the Shadow Method will work great. For example letting M =
√
N we can see that as SNP density gets thicker
the percentage of the genome where the SM and S disagree quickly goes to zero as N goes infinity. However as
discussed in Section 3.3, as the marker density increases the assumptions that underlie our estimate will be become
less and less realistic (especially the independence of the markers), and caution is required.
D. Key Theorem
Set Up: Let D be a set, let rp be a process that selects a random point from D, and let RS be a process that selects
a random subset of D.
For Simplicity: Assume D is finite and that P (x ∈ RS) 6= 0 for all x (like the real human genome).
Definition: Let (RS | x ∈ RS) denote the result of the process conditioned to contain x.
Lemma: Upon witnessing E = (RS | rp ∈ RS) we have
P (rp = x | (RS | rp ∈ RS) = E) ∼ P (rp = x)
P (x ∈ RS)χE(x),
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where χE is the indicator function on E.
Proof: Recall Bayes Theorem
P (A | B) = P (B | A)P (A)
P (B)
and notice
P ((RS | x ∈ RS) = E) = P (RS = E | x ∈ RS).
From these observations, we have that P (rp = x | (RS | rp ∈ RS) = E)
= P ((RS | rp ∈ RS) = E | rp = x) P (rp = x)
P ((RS | rp ∈ RS) = E)
= P ((RS | x ∈ RS) = E) P (rp = x)
P ((RS | rp ∈ RS) = E)
= P (RS = E | x ∈ RS) P (rp = x)
P ((RS | rp ∈ RS) = E)
= P (x ∈ RS | RS = E)P (RS = E)
P (x ∈ RS)
P (rp = x)
P ((RS | rp ∈ RS) = E)
= χE(x)
(
P (RS = E)
P ((RS | rp ∈ RS) = E)
)(
P (rp = x)
P (x ∈ RS)
)
as asserted.
QED
Comment: This lemma captures the intuitive fact that if a point is relatively unlikely to be in RS but turns up in
E, then this point is more likely to be the point upon which RS was conditioned. This could be useful in situations
in which there is a great deal of prior information regarding the disease loci. However when applying this lemma to
derive the key theorem we assume that the disease’s location is a priori totally unknown (so P (rp = x) is independent
of x) and that make the Medelian assumption (P (x ∈ RS) is independent of x).
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